Literature DB >> 15233580

Epilepsia partialis continua possibly caused by cerebellar lesion.

Tatiana Vander1, Mark Medvedovsky, Yuval Herishanu.   

Abstract

The cerebellum is known to have inhibitory effects on seizures. Nevertheless, cerebellar dysplastic lesions can be epileptogenic. We report a patient presenting with epilepsia partialis continua (EPC) following a hemorrhagic cerebellar lesion. Possible pathophysiological mechanisms are discussed.

Entities:  

Mesh：

Year:  2004        PMID： 15233580     DOI： 10.1080/14734220410026220

Source DB:  PubMed          Journal:  Cerebellum        ISSN： 1473-4222            Impact factor:   3.847


  13 in total

1.  Crossed cerebellar diaschisis and brain tumor biochemistry studied with positron emission tomography, [18F]fluorodeoxyglucose and [11C]methionine.

Authors:  A Otte; U Roelcke; K von Ammon; O Hausmann; R P Maguire; J Missimer; J Müller-Brand; E W Radü; K L Leenders
Journal:  J Neurol Sci       Date:  1998       Impact factor: 3.181

Review 2.  [Cerebral crossed diaschisis caused by cerebellar lesion: role of the cerebellum in mental functions].

Authors:  E Attig; M I Botez; C Hublet; C Vervonck; J Jacquy; A Capon
Journal:  Rev Neurol (Paris)       Date:  1991       Impact factor: 2.607

3.  Epilepsia partialis continua in multiple sclerosis.

Authors:  D C Hess; K D Sethi
Journal:  Int J Neurosci       Date:  1990-01       Impact factor: 2.292

4.  Wakefulness-sleep modulation of EEG-EMG epileptiform activities: a quantitative study on a child with intractable epilepsia partialis continua.

Authors:  M Velasco; F Velasco; H Alcalá; A E Díaz de León
Journal:  Int J Neurosci       Date:  1990-10       Impact factor: 2.292

5.  The role of subcortical structures in human epilepsy.

Authors:  Andrew D. Norden; Hal Blumenfeld
Journal:  Epilepsy Behav       Date:  2002-06       Impact factor: 2.937

6.  Crossed cerebellar hyperperfusion in symptomatic epilepsy--two case reports.

Authors:  A Umemura; T Suzuka
Journal:  Neurol Med Chir (Tokyo)       Date:  2000-01       Impact factor: 1.742

7.  Hemifacial seizure of cerebellar ganglioglioma origin: seizure control by tumor resection.

Authors:  J H Chae; S K Kim; K C Wang; K J Kim; Y S Hwang; B K Cho
Journal:  Epilepsia       Date:  2001-09       Impact factor: 5.864

8.  Epilepsia partialis continua--a clinical and electroencephalography study.

Authors:  J D Pandian; S V Thomas; B Santoshkumar; K Radhakrishnan; P S Sarma; S Joseph; C Kesavadas
Journal:  Seizure       Date:  2002-10       Impact factor: 3.184

Review 9.  Focal motor seizures with secondary generalization arising in the cerebellum. Case report and review of the literature.

Authors:  Ali H Mesiwala; John D Kuratani; Anthony M Avellino; Theodore S Roberts; Marcio A Sotero; Richard G Ellenbogen
Journal:  J Neurosurg       Date:  2002-07       Impact factor: 5.115

10.  MR evaluation of crossed and uncrossed cerebral-cerebellar diaschisis.

Authors:  A Chakravarty
Journal:  Acta Neurol Scand       Date:  2003-07       Impact factor: 3.209
View more
  4 in total

1.  Subcortical pathophysiological mechanisms in epilepsia partialis continua.

Authors:  José Berciano
Journal:  Cerebellum       Date:  2004       Impact factor: 3.847

Review 2.  Lesional cerebellar epilepsy: a review of the evidence.

Authors:  Niels A Foit; Vera van Velthoven; Reinhard Schulz; Ingmar Blümcke; Horst Urbach; Friedrich G Woermann; Christian G Bien
Journal:  J Neurol       Date:  2016-06-03       Impact factor: 4.849

3.  Differential expression of cerebellar metabotropic glutamate receptors mGLUR2/3 and mGLUR4a after the administration of a convulsant drug and the adenosine analogue cyclopentyladenosine.

Authors:  Elena Silvia Girardi; Juan Canitrot; Marta Antonelli; Nélida N González; Héctor Coirini
Journal:  Neurochem Res       Date:  2007-03-31       Impact factor: 4.414

4.  Ictal vomiting after cerebellar hemorrhage: A case report.

Authors:  Shunsuke Nomura; Yuichi Kubota; Hidetoshi Nakamoto; Takakazu Kawamata
Journal:  Epilepsy Behav Case Rep       Date:  2018-09-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.